相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antitumor Effect of Paclitaxel Is Mediated by Inhibition of Myeloid-Derived Suppressor Cells and Chronic Inflammation in the Spontaneous Melanoma Model
Alexandra Sevko et al.
JOURNAL OF IMMUNOLOGY (2013)
Myeloid-Derived Suppressor Cells Interact with Tumors in Terms of Myelopoiesis, Tumorigenesis and Immunosuppression: Thick as Thieves
Alexandra Sevko et al.
JOURNAL OF CANCER (2013)
Immune effects of 5-fluorouracil Ambivalence matters
Francois Ghiringhelli et al.
ONCOIMMUNOLOGY (2013)
Differential effects of low-dose decitabine on immune effector and suppressor responses in melanoma-bearing mice
Pierre L. Triozzi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Cyclophosphamide-induced Myeloid-derived Suppressor Cell Population Is Immunosuppressive But Not Identical to Myeloid-derived Suppressor Cells Induced By Growing TC-1 Tumors
Romana Mikyskova et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Paclitaxel promotes differentiation of myeloid-derived suppressor cells into dendritic cells in vitro in a TLR4-independent manner
Tillmann Michels et al.
JOURNAL OF IMMUNOTOXICOLOGY (2012)
Histone deacetylase inhibition facilitates GM-CSF-mediated expansion of myeloid-derived suppressor cells in vitro and in vivo
Brian R. Rosborough et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Coordinated regulation of myeloid cells by tumours
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Immunotherapy augments the effect of 5-azacytidine on HPV16-associated tumours with different MHC class I-expression status
J. Simova et al.
BRITISH JOURNAL OF CANCER (2011)
Generation of antitumor response by IL-2-transduced JAWS II dendritic cells
Joanna Rossowska et al.
IMMUNOBIOLOGY (2011)
Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting
Luis I. Sanchez-Abarca et al.
BLOOD (2010)
Generation of antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2'-deoxycytidine
Irina Daurkin et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
Julie Vincent et al.
CANCER RESEARCH (2010)
A Novel Chemoimmunomodulating Property of Docetaxel: Suppression of Myeloid-Derived Suppressor Cells in Tumor Bearers
Krithika N. Kodumudi et al.
CLINICAL CANCER RESEARCH (2010)
Multicenter, Phase II Study of Decitabine for the First-Line Treatment of Older Patients With Acute Myeloid Leukemia
Amanda F. Cashen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy
C. Marcela Diaz-Montero et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Therapeutic targeting of myeloid-derived suppressor cells
Stefano Ugel et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
Cyclophosphamide and cancer: golden anniversary
Ashkan Emadi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity
Kiavash Movahedi et al.
BLOOD (2008)
Subsets of myeloid-derived suppressor cells in tumor-bearing mice
Je-In Youn et al.
JOURNAL OF IMMUNOLOGY (2008)
Epigenetic control of the immune escape mechanisms in malignant carcinomas
A. Francesca Setiadi et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia
William Blum et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity
Alessio Nencioni et al.
CLINICAL CANCER RESEARCH (2007)
L-arginine availability regulates T-lymphocyte cell-cycle progression
Paulo C. Rodriguez et al.
BLOOD (2007)
Epigenetic regulation of immune escape genes in cancer
Thomas B. Tomasi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Decitabine improves patient outcomes in myelodysplastic syndromes - Resuits of a Phase III randomized study
H Kantarjian et al.
CANCER (2006)
Role of immature myeloid cells in mechanisms of immune evasion in cancer
S Kusmartsev et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity
E Suzuki et al.
CLINICAL CANCER RESEARCH (2005)
Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: A mechanism of tumor evasion
AH Zea et al.
CANCER RESEARCH (2005)
Derangement of immune responses by myeloid suppressor cells
P Serafini et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses
PC Rodriguez et al.
CANCER RESEARCH (2004)
Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species
S Kusmartsev et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Immunisation with modified HPV16 E7 genes against mouse oncogenic TC-1 cell sublines with downregulated expression of MHC class I molecules
M Smahel et al.
VACCINE (2003)
Cyclophosphamide induces the development of early myeloid cells suppressing tumor cell growth by a nitric oxide-dependent mechanism
B Peláez et al.
JOURNAL OF IMMUNOLOGY (2001)
分享论文
